Precursor supply for erythromycin biosynthesis: engineering of propionate assimilation pathway based on propionylation modification.

Di You,Miao-Miao Wang,Bin-Cheng Yin,Bang-Ce Ye
DOI: https://doi.org/10.1021/acssynbio.8b00396
IF: 5.249
2019-01-01
ACS Synthetic Biology
Abstract:Erythromycin is necessary in the medical treatment and known to be biosynthesized with propionyl-CoA as direct precursor. Over-supply of propionyl-CoA induced hyper propionylation, which was demonstrated harmful for erythromycin synthesis in Saccharopolyspora erythraea. Herein, we identified three propionyl-CoA synthetases regulated by propionylation and one propionyl-CoA synthetase SACE_1780 revealed resistance to propionylation. A practical strategy for raising the precursor (propionyl-CoA) supply bypassing the feedback inhibition caused by propionylation was developed through two approaches: deletion of the propionyltransferase AcuA and SACE_1780 overexpression. The constructed ΔacuA strain presented a 10 % increase in erythromycin yield, SACE_1780 overexpression strain produced 33 % higher erythromycin yield than the wildtype strain NRRL2338 and 22% higher erythromycin yield than the industrial high yield Ab strain. These findings uncover the role of protein acylation in precursor supply for antibiotics biosynthesis, and provide efficient post-translational modification-metabolic engineering strategy (named as PTM-ME) in synthetic biology for improvement of secondary metabolites.
What problem does this paper attempt to address?